Could a drug calm the immune attack in aicardi goutières syndrome?
Disease control
Completed
This study tested the drug baricitinib in 54 people with Aicardi Goutières Syndrome (AGS), a rare genetic disorder where the immune system attacks the brain. The goal was to see if the drug could safely slow or stop the disease by reducing harmful inflammation. Researchers measur…
Phase: PHASE2 • Sponsor: Adeline Vanderver, MD • Aim: Disease control
Last updated Jun 17, 2026 04:40 UTC